AU2002216499A1 - Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them - Google Patents

Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them

Info

Publication number
AU2002216499A1
AU2002216499A1 AU2002216499A AU1649902A AU2002216499A1 AU 2002216499 A1 AU2002216499 A1 AU 2002216499A1 AU 2002216499 A AU2002216499 A AU 2002216499A AU 1649902 A AU1649902 A AU 1649902A AU 2002216499 A1 AU2002216499 A1 AU 2002216499A1
Authority
AU
Australia
Prior art keywords
sequences
polynucleotide
sequence
seq
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002216499A
Other languages
English (en)
Inventor
James Dekker
Matthew Glenn
Ilkka J Havukkala
Mark William Lubbers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genesis Research and Development Corp Ltd
ViaLactia Biosciences NZ Ltd
Original Assignee
Genesis Research and Development Corp Ltd
ViaLactia Biosciences NZ Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genesis Research and Development Corp Ltd, ViaLactia Biosciences NZ Ltd filed Critical Genesis Research and Development Corp Ltd
Publication of AU2002216499A1 publication Critical patent/AU2002216499A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/335—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/02—Making cheese curd
    • A23C19/032—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
    • A23C19/0323—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin using only lactic acid bacteria, e.g. Pediococcus and Leuconostoc species; Bifidobacteria; Microbial starters in general
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C2220/00—Biochemical treatment
    • A23C2220/20—Treatment with microorganisms
    • A23C2220/202—Genetic engineering of microorganisms used in dairy technology
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Polymers & Plastics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
AU2002216499A 2000-11-28 2001-11-28 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them Abandoned AU2002216499A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09724623 2000-11-28
US09/724,623 US6476209B1 (en) 2000-11-28 2000-11-28 Polynucleotides, materials incorporating them, and methods for using them
PCT/NZ2001/000286 WO2002044383A1 (fr) 2000-11-28 2001-11-28 Polynucleotides et polypeptides de lactobacillus rhamnosus et procedes d'utilisation correspondants

Publications (1)

Publication Number Publication Date
AU2002216499A1 true AU2002216499A1 (en) 2002-06-11

Family

ID=24911171

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002216499A Abandoned AU2002216499A1 (en) 2000-11-28 2001-11-28 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them

Country Status (4)

Country Link
US (1) US6476209B1 (fr)
AU (1) AU2002216499A1 (fr)
NZ (2) NZ526078A (fr)
WO (1) WO2002044383A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7351578B2 (en) 1999-12-10 2008-04-01 Invitrogen Corp. Use of multiple recombination sites with unique specificity in recombinational cloning
US7125698B2 (en) * 1999-08-09 2006-10-24 Matthew Glenn Polynucleotides, materials incorporating them, and methods for using them
NZ536894A (en) * 2000-08-08 2006-04-28 Vialactia Bioscience Nz Ltd Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US20050124568A1 (en) * 2001-05-18 2005-06-09 Sirna Therapeutics, Inc. RNA interference mediated inhibition of acetyl-CoA-carboxylase gene expression using short interfering nucleic acid (siNA)
US20090137513A1 (en) * 2002-02-20 2009-05-28 Sirna Therapeutics, Inc. RNA Interference Mediated Inhibition of Acetyl-CoA-Carboxylase Gene Expression Using Short Interfering Nucleic Acid (siNA)
JP4850698B2 (ja) * 2003-04-25 2012-01-11 ノース・キャロライナ・ステイト・ユニヴァーシティ 細胞表面タンパク質相同体をコードするアシドフィルス菌核酸配列及びその使用
DE602004032144D1 (de) * 2003-06-23 2011-05-19 Univ North Carolina State Für fructooligosaccharid-nutzende verbindungen codierende nukleinsäuren aus lactobacillus acidophilus und verwendungen davon
EP1697534B1 (fr) 2003-12-01 2010-06-02 Life Technologies Corporation Molecule d'acide nucleique contenant des sites de recombinaison et leurs procedes d'utilisation
US7455992B2 (en) * 2004-02-23 2008-11-25 North Carolina State University Lactobacillus acidophilus nucleic acid sequences encoding protease homologues and uses therefore
US7459289B2 (en) 2004-03-08 2008-12-02 North Carolina State University Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor
US7608700B2 (en) * 2004-03-08 2009-10-27 North Carolina State University Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor
US7550576B2 (en) * 2004-08-09 2009-06-23 North Carolina State University Nucleic acid sequences encoding two-component sensing and regulatory proteins, antimicrobial proteins and uses therefor
JP2008517628A (ja) * 2004-10-27 2008-05-29 ノース カロライナ ステイト ユニヴァーシティー ラクトバチルス・アシドフィルス核酸及びその使用
US7495092B2 (en) * 2005-01-14 2009-02-24 North Carolina State University Compositions comprising promoter sequences and methods of use
CN1313599C (zh) * 2005-07-21 2007-05-02 山东大学 一种筛选转糖基β－半乳糖苷酶产生菌的方法
US20110262400A1 (en) * 2008-06-27 2011-10-27 University Of Guelph Probiotic bacterial molecules and their use in methods to treat/prevent infection by harmful bacteria and to provide nutritional health
US20110020936A1 (en) * 2009-07-24 2011-01-27 Pioneer Hi-Bred International, Inc. Method for electroporation of lactobacillus buchneri with nucleic acid
EP2277989A1 (fr) 2009-07-24 2011-01-26 Technische Universiteit Delft Production d'éthanol dépourvu de glycérol par fermentation
WO2015021530A1 (fr) 2013-08-12 2015-02-19 Mansel Griffiths Méthodes et compositions antivirales comprenant des molécules bactériennes probiotiques
CN114634568B (zh) * 2020-12-16 2024-04-09 深圳市菲鹏生物治疗股份有限公司 Bcma的抗体及其应用
CN114874296B (zh) * 2022-04-30 2023-09-08 浙江工商大学 抗耐药性金黄色葡萄球菌的细菌素的分离纯化方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8701378A (nl) 1987-06-12 1989-01-02 Nl Zuivelonderzoek Inst Dna-fragmenten, omvattende een melkzuurbacterie-specifiek regulatorgebied voor het tot expressie brengen van voor normaliter heterologe eiwitten coderende genen, op dergelijke dna-fragmenten gebaseerde recombinant-plasmiden, microorganismen, in het bijzonder melkzuurbacterien, welke deze recombinant-plasmiden, bevatten alsmede de met behulp van voorstaande microorganismen bereide heterologe eiwitten resp. produkten.
NZ536894A (en) 2000-08-08 2006-04-28 Vialactia Bioscience Nz Ltd Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them

Also Published As

Publication number Publication date
NZ534397A (en) 2005-07-29
NZ526078A (en) 2005-01-28
US6476209B1 (en) 2002-11-05
WO2002044383A1 (fr) 2002-06-06

Similar Documents

Publication Publication Date Title
US7052896B2 (en) Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
AU2002216499A1 (en) Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
US7125698B2 (en) Polynucleotides, materials incorporating them, and methods for using them
AU2001284558A1 (en) Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
US7026463B2 (en) Polynucleotides and polypeptides, materials incorporating them and methods for using them
US7824894B2 (en) Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof
US6544772B1 (en) Polynucleotides, materials incorporating them, and methods for using them
WO2006076628A2 (fr) Compositions renfermant des sequences promoteurs et procedes d'utilisation
US20060134745A1 (en) Nucleic acid sequences encoding two-component sensing and regulatory proteins, antimicrobial proteins and uses therefor
US20050202437A1 (en) Polynucleotides and polypeptides, materials incorporating them and methods for using them
US20060099623A1 (en) Polynucleotides and polypeptides isolated from lactobacillus and methods for their use
AU2003288826A1 (en) Polynucleotides and polypeptides isolated from lactobacillus rhamnosus hn001 materials incorporating them and methods for using them
US20230404093A1 (en) Protein having fermented milk viscosity improving effect, fermented milk using the same and method for producing the same
Ventura et al. Identification and Characterization of Novel

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application